Developing research leaders at the intersection of malnutrition and tuberculosis in Tanzania
Developing research leaders at the intersection of malnutrition and tuberculosis in Tanzania
批准号:
10588197
负责人:
Scott K Heysell
金额:
$24.83万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-03-01 至 2027-02-28
关键词:
AfricaCOVID-19CaringCategoriesCessation of lifeClinical ResearchCommunicable DiseasesCommunicationCommunitiesDeveloping CountriesDiabetes MellitusDiseaseEducationEmerging Communicable DiseasesEuropeanFacultyFoundationsFundingGrantGrowthHealthInfectious Diseases ResearchInfrastructureInternationalLeadLeadershipLearningMalnutritionMedicalMentorsNeeds AssessmentPolicy MakingPostdoctoral FellowPovertyPublic HealthReportingResearchResearch InstituteResearch TrainingScientistStructureTanzaniaTestingTrainingTraining ProgramsTuberculosisUnited States National Institutes of HealthUniversitiesVirginiaWorld Health OrganizationWritingcareercollegedesigndoctoral studentexperienceglobal healthhealth equityminority healthnutritionpost-doctoral trainingskillsundergraduate student
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY / ABSTRACT
This application for a new Global Infectious Diseases Research Training program (GIDRTP) at the University of
Virginia (UVA) extends decades of training global leaders in diseases of poverty and infectious diseases through
cycles of support of International Training and Research in Emerging Infectious Diseases, Actions for Building
Capacity, Minority Health International Research Training, and Fogarty GIDRTPs. These prior experiences
provide lessons learned and tested mechanisms for developing trainees into independent public health
scientists. Despite the prior focus on early stage trainees such as undergraduate, Masters or doctoral students,
we have noted unique barriers in progression through postdoctoral training to research leadership in Tanzania.
We performed a needs assessment among Tanzanian postdoctoral scientists in 2021 which confirmed this
observation and outlined gaps and opportunities with which to structure a postdoctoral focused GIDRTP. UVA,
the Division of Infectious Diseases and International Health, and the Center for Global Health Equity have been
at the forefront of research and training in malnutrition and its infectious consequences for decades. In non-
pandemic periods, tuberculosis (TB) is the leading killer from a curable infectious disease. COVID-19 has further
disrupted TB care and is projected to increase deaths from TB by 20% over the next five years. Malnutrition,
both undernutrition and poor nutrition leading to conditions such as diabetes mellitus, is the most important driver
of TB disease globally. Therefore, this GIDRTP aims to strengthen existing educational and research linkages
with the UVA and the Kilimanjaro Christian Medical University College/ Kilimanjaro Clinical Research Institute
(KCMUCo/KCRI) in Tanzania, to support Tanzanian postdoctoral trainees' growth to research leaders working
at the intersection of malnutrition and TB.
We aim to train 6 postdoctoral scientists with 3 years of support each through an individualized research
leadership plan based on the framework of the Path to Research Leadership in Africa Report (2020). In addition
to matching postdoctoral fellows to Tanzanian and UVA mentors, the individualized research leadership plan will
include assessment by Lead Educators and core programmatic faculty including a biostatistician to design
personalized coursework and skills building toward the metric categories of research team management,
communication, grant writing, professionalism and career trajectory. We will harness the current infrastructure
of funding from the National Institutes of Health, Bill and Melinda Gates Foundation, European and Developing
Countries Trials Partnership, World Health Organization and the Danish Ministry of Foreign Affairs for TB and
malnutrition research in Tanzania, and we expect to launch the careers of junior scientists and content leaders
that will compete for independent funding, set research agendas, make policy and benefit their communities in-
line with the World Health Organization's End TB Strategy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Developing research leaders at the intersection of malnutrition and tuberculosis in Tanzania
-
批准号:10461564
-
项目类别:
-
资助金额:$25.03万
-
财政年份:2022
-
负责人:Scott K Heysell
-
依托单位:
Developing research leaders at the intersection of malnutrition and tuberculosis in Tanzania
-
批准号:10875013
-
项目类别:
-
资助金额:$15.0万
-
财政年份:2022
-
负责人:Scott K Heysell
-
依托单位:
A randomized clinical trial of early empiric anti-Mycobacterium tuberculosis therapy for sepsis in sub-Saharan Africa
-
批准号:10084642
-
项目类别:
-
资助金额:$68.28万
-
财政年份:2020
-
负责人:Scott K Heysell
-
依托单位:
A randomized clinical trial of early empiric anti-Mycobacterium tuberculosis therapy for sepsis in sub-Saharan Africa
-
批准号:10443820
-
项目类别:
-
资助金额:$65.78万
-
财政年份:2020
-
负责人:Scott K Heysell
-
依托单位:
A randomized clinical trial of early empiric anti-Mycobacterium tuberculosis therapy for sepsis in sub-Saharan Africa
-
批准号:10653094
-
项目类别:
-
资助金额:$66.95万
-
财政年份:2020
-
负责人:Scott K Heysell
-
依托单位:
A randomized clinical trial of early empiric anti-Mycobacterium tuberculosis therapy for sepsis in sub-Saharan Africa
-
批准号:10265511
-
项目类别:
-
资助金额:$66.28万
-
财政年份:2020
-
负责人:Scott K Heysell
-
依托单位:
Urine Colorimetry for Tuberculosis Pharmacokinetics Evaluation in Children and Adults
-
批准号:10168710
-
项目类别:
-
资助金额:$45.83万
-
财政年份:2018
-
负责人:Scott K Heysell
-
依托单位:
Urine Colorimetry for Tuberculosis Pharmacokinetics Evaluation in Children and Adults
-
批准号:10221522
-
项目类别:
-
资助金额:$79.25万
-
财政年份:2018
-
负责人:Scott K Heysell
-
依托单位:
Urine Colorimetry for Tuberculosis Pharmacokinetics Evaluation in Children and Adults
-
批准号:10245319
-
项目类别:
-
资助金额:$76.79万
-
财政年份:2018
-
负责人:Scott K Heysell
-
依托单位:
Urine Colorimetry for Tuberculosis Pharmacokinetics Evaluation in Children and Adults
-
批准号:10320620
-
项目类别:
-
资助金额:$20.26万
-
财政年份:2018
-
负责人:Scott K Heysell
-
依托单位:
Urine Colorimetry for Tuberculosis Pharmacokinetics Evaluation in Children and Adults
-
批准号:10488657
-
项目类别:
-
资助金额:$66.91万
-
财政年份:2018
-
负责人:Scott K Heysell
-
依托单位:
Individualized approaches to the HIV/TB epidemic among polysubstance users in Irkutsk
-
批准号:9352558
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2017
-
负责人:Scott K Heysell
-
依托单位:
Clinical Impact of Anti-TB Drug Levels and M. Tuberculosis Susceptibility
-
批准号:8690758
-
项目类别:
-
资助金额:$12.99万
-
财政年份:2012
-
负责人:Scott K Heysell
-
依托单位:
Clinical Impact of Anti-TB Drug Levels and M. Tuberculosis Susceptibility
-
批准号:8277591
-
项目类别:
-
资助金额:$12.99万
-
财政年份:2012
-
负责人:Scott K Heysell
-
依托单位:
Clinical Impact of Anti-TB Drug Levels and M. Tuberculosis Susceptibility
-
批准号:8512655
-
项目类别:
-
资助金额:$12.99万
-
财政年份:2012
-
负责人:Scott K Heysell
-
依托单位:
国内基金
海外基金
登录
查看更多内容
CEACAM5调控Galectin-9介导的CD4+T细胞极化在COVID-19肠屏障损伤的作用机制研究
-
批准号:82370569
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:李啸峰
-
依托单位:
COVID-19疫情对我国儿童生长发育影响的异质性研究
-
批准号:42371429
-
项目类别:面上项目
-
资助金额:52.00万元
-
批准年份:2023
-
负责人:张知新
-
依托单位:
传染病模型的稳态切换过程研究及其在治疗COVID-19中的应用
-
批准号:LQ23A010016
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:罗敏
-
依托单位:
“湿漫膜原”视角下研究加味达原饮重塑COVID-19“免疫炎症稳态”的分子机制:TLR4介导IRF3/NF-κB通路串扰
-
批准号:82374291
-
项目类别:面上项目
-
资助金额:48万元
-
批准年份:2023
-
负责人:张传涛
-
依托单位:
COVID-19中线粒体囊泡抑制CD8+T细胞记忆分化的机制研究
-
批准号:82300018
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:利时雨
-
依托单位:
COVID-19疫情爆发后武汉地区儿童副流感病毒3型的流行趋势和进化规律研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:
-
依托单位:
基于 GDF15-IL6 信号轴探究扶正解毒方逆转血管内皮衰老治疗COVID-19的作用与机制
-
批准号:82374392
-
项目类别:面上项目
-
资助金额:48万元
-
批准年份:2023
-
负责人:张忠德
-
依托单位:
COVID-19疫苗同源、异源加强剂次细胞免疫与体液免疫效应的前瞻性队列研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2023
-
负责人:蔡琳
-
依托单位:
多维不平稳和长记忆性的复杂整值时间序列的建模及其在Covid-19研究中的应用
-
批准号:12301358
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:许晓菲
-
依托单位:
基于人源细胞3D培养和精密肺切片技术探讨慢阻肺患者COVID-19易感机制研究
-
批准号:LY23H190003
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:钱国清
-
依托单位: